# Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm in Traumatic Subarachnoid Hemorrhage

> **NCT07252505** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Trauma and Emergency Care

## Interventions

- **DRUG:** Magnesium Sulfate 10 MG/ML

## Key facts

- **NCT ID:** NCT07252505
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07252505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07252505, "Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm in Traumatic Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07252505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*